Apolipoprotein E, synthesized from APOE ε4, is linked to abnormal protein processing, which is present in AD patients; in addition, apolipoprotein E is able to cooperate with amyloid-β aggregates and it promotes the phosphorylation of tau in neurons, inducing neurodegeneration [17,111]. The gene discussed is MAPT; the disease is Alzheimer disease.